Richmond Research & Pharmaceuticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.14 M
as on 02-12-2023
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
About Richmond Research & Pharmaceuticals Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2019 (FY 2018-2019). It's Total Obligation of Contribution is Rs 0.14 M as per MCA.
- CIN/LLPIN/FCRN
AAK-6036
- Incorporation Date
15 Sep 2017
- Date of Accounts and Solvency Statement
31 Mar 2019
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Richmond Research & Pharmaceuticals Llp?
Designated Partners (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hardik Patel  | Designated Partner | 15-Sep-2017 | Current |
| Snehalkumar Patel | Designated Partner | 15-Sep-2017 | Current |
| Manish Patel | Designated Partner | 15-Sep-2017 | Current |
| Yash Patel | Designated Partner | 15-Sep-2017 | Current |
| Pragneshkumar Patel | Designated Partner | 15-Sep-2017 | Current |
| Sandipkumar Patel | Designated Partner | 15-Sep-2017 | Current |
Financial Performance of Richmond Research & Pharmaceuticals Llp.
Enhance accessibility to Richmond Research & Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Richmond Research & Pharmaceuticals Llp?
Unlock access to Richmond Research & Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shrifal Minerals Private LimitedActive 6 years 2 monthsHardik Patel, Snehalkumar Patel and 1 more are mutual person
- Shree Sumukh Finbiz Private LimitedActive 1 year 7 months
Hardik Patel and Snehalkumar Patel are mutual person
- Zoster Minerals Private LimitedActive 8 months 21 days
Snehalkumar Patel and Sandipkumar Patel are mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Richmond Research & Pharmaceuticals Llp?
Unlock and access historical data on people associated with Richmond Research & Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Richmond Research & Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Richmond Research & Pharmaceuticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.